Domov › BOPC › Texas › Dallas

Klinične študije za BOPC v Dallas, TX

12 študij za BOPC išče udeležence na lokacijah v Dallas in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Vključevanje udeležencevFaza 3

Research Site, Dallas

Starost 40–80 · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Vključevanje udeležencevFaza 3

IntraCare- Site Number : 8400034, Dallas

Starost 40–80 · Vsi spoli · Posodobljeno 1. okt. 2026 · NCT07190222

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Vključevanje udeležencevFaza 3

Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas

Starost 40–80 · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT07190209

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Vključevanje udeležencev

University of Texas Southwestern, Dallas

Starost 40–80 · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06035120

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Vključevanje udeležencevFaza 2

Research Site, Dallas

Starost 40 in več · Vsi spoli · Posodobljeno 9. sep. 2026 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Vključevanje udeležencevFaza 3

Research Site, Dallas

Starost 40–80 · Vsi spoli · Posodobljeno 3. sep. 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Vključevanje udeležencevFaza 2/3

Alina Clinical Trials, LLC., Dallas

Starost 35–80 · Vsi spoli · Posodobljeno 31. avg. 2026 · NCT07363694

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

Vključevanje udeležencevFaza 3

GC2501 Study Site 109, Dallas

Starost 18–80 · Vsi spoli · Posodobljeno 11. avg. 2026 · NCT07555483

STRIVE Post-Market Registry Study

Vključevanje udeležencevOpazovalna študija

Baylor Scott & White Research Institute, Dallas
University of Texas Southwestern, Dallas

Starost 18 in več · Vsi spoli · Posodobljeno 3. avg. 2026 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Vključevanje udeležencevFaza 3

GSK Investigational Site, Dallas

Starost 40–75 · Vsi spoli · Posodobljeno 28. jul. 2026 · NCT07177339

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Vključevanje udeležencevOpazovalna študija

Liver Center of Texas, Dallas

Starost 18 in več · Vsi spoli · Posodobljeno 10. jul. 2026 · NCT05181826

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Vključevanje udeležencevFaza 3

GSK Investigational Site, Dallas

Starost 40–80 · Vsi spoli · Posodobljeno 9. apr. 2026 · NCT06961214

Študije za BOPC v drugih mestih

Druge študije v Dallas

Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.